Paris, France

Anne Dejean

USPTO Granted Patents = 8 

Average Co-Inventor Count = 4.7

ph-index = 3

Forward Citations = 140(Granted Patents)


Company Filing History:


Years Active: 1992-2009

Loading Chart...
8 patents (USPTO):Explore Patents

Title: The Innovative Journey of Anne Dejean in Paris

Introduction

Anne Dejean, a prominent inventor located in Paris, France, has made significant contributions to the field of molecular biology. With an impressive portfolio of eight patents, her innovative work primarily focuses on retinoic acid receptors and their implications in diseases such as hepatocellular carcinoma (HCC).

Latest Patents

Dejean's latest patents reveal her expertise in identifying synthetic ligands for retinoic acid receptor beta (RAR-β). One method involves providing a sample with a synthetic compound and exposing it to cultured cells containing RAR-β. By determining the upregulation of a gene encoding RAR-β compared to a control gene, she successfully identifies potential synthetic ligands. Another significant patent addresses steroid and thyroid hormone receptor-related gene expression in human hepatocellular carcinoma. This work utilizes a previously isolated hepatitis B virus (HBV) integration to clone corresponding complementary DNA from a human liver cDNA library, revealing key insights into hepatocellular carcinoma.

Career Highlights

Anne Dejean has had a notable career at esteemed institutions such as the Institut Pasteur. Her research and inventions have played a vital role in advancing our understanding of hormone receptors and their genetic expressions, especially in relation to liver diseases.

Collaborations

Throughout her career, Dejean has collaborated with distinguished scientists including Pierre Tiollais and Agnes Marchio. These collaborations have further enhanced the impact of her research and innovation in the scientific community.

Conclusion

Anne Dejean exemplifies the spirit of innovation through her dedicated research and impactful patents. Her work not only contributes to the scientific understanding of retinoic acid receptors but also showcases the potential of synthetic compounds in medical applications. As she continues to forge her path in the world of inventions, her legacy as a trailblazer in molecular biology is undeniable.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…